EUNASH
Meeting category
Date(s)
22 Nov 2019 - 23 Nov 2019
Location
Barcelona, Spain
Organizer

European Workshop on NASH in Clinical Practice 2019

Related Enduring Materials

Enduring Materials

22 November 2019

- 09:00
09:00 CEST
Workshop Opening
Session 1: Natural History and Epidemiology - 09:10
09:10 CEST
Natural History of NASH
Emmanuel Tsochatzis, MD, MSc, FEBTM, FRCP, PhD
Royal Free Hospital, United Kingdom
09:40 CEST
NASH Epidemiology and policy
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
10:10 CEST
NASH Diagnosis and Management in General Practice
Rachel Pryke, MBBS, MRCGP, FRCP
Winyates Health Centre, United Kingdom
Session 2: Clinical Management of NASH - Diabetes and Obesity - 11:30
11:30 CEST
Practical Guidance Obesity Management - Introductory Talk
Jude Oben
Jude Oben, MD
University College London, United Kingdom
12:00 CEST
Practical Guidance Diabetes management - Introductory Talk
Beatriz Gonzalez, MD
Hospital Universitario Virgen Macarena, Spain
Session 3: Clinical Management of NASH - Special Populations - 13:45
13:45 CEST
Management of Lean NASH
Ramy Younes, MD
University of Turin, Turin, Italy
14:15 CEST
Practical Guidance on Pediatrics NAFLD (incl. clinical cases)
Alastair Baker, MB, ChB, FRCP, FRCPCH, MBA
King's College Hospital NHS Foundation Trust, United Kingdom
14:45 CEST
NASH in HIV
Berend van Welzen, MD
UMC Utrecht, Netherlands
Session 4: NASH Management - 16:00
16:00 CEST
New Biomarkers in NAFLD
Manuel Romero-Gomez, MD
Virgen del Rocío University Hospital / University of Seville, Spain
16:30 CEST
How to Implement a Healthy Lifestyle in NAFLD/NASH Patients
Shira Zelber-Sagi, BSc, RD, PhD
University of Haifa / The Tel-Aviv Medical Center, Israel
17:00 CEST
Roundtable Discussion: The Interface of Primary and Secondary Care
Emmanuel Tsochatzis
Moderator: Emmanouil Tsochatzis, MD, PhD
Royal Free Hospital, United Kingdom
19:30 CEST
Workshop Dinner

23 November 2019

Session 5: NASH and Comorbidities - 09:00
09:00 CEST
NASH/NAFLD as Cause for HCC
Helen Reeves, MD, PhD
Newcastle Universtity, United Kingdom
09:20 CEST
Drug-Induced Liver Injury and NASH
Raúl Andrade, MD, PhD
University Hospital Virgen de la Victoria, Malaga, Spain
09:40 CEST
Cardiovascular Risk in NAFLD
Jörn M. Schattenberg, MD
Saarland University Medical Center, Germany
10:00 CEST
NASH and Immune-Mediated Diseases
Maria Teresa Arias Loste, MD, PhD
Hospital Universitario Marques de Valdecilla, Santander, Spain
Session 6: Future Treatment and Management Options - 11:00
11:00 CEST
Invited Lecturer
Vlad Ratziu, MD, PhD
Pierre and Marie Curie University, Paris, France
11:30 CEST
Patient Perspective
Maite Pujol
ASSCAT, Barcelona Spain
Teresa Casanovas, MD
ELPA, ASSCAT, Barcelona, Spain
11:45 CEST
Round Table Discussion: Current guidelines - still relevant or in need for review?
12:30 CEST
Closure of the Workshop
Overview
Welcome

We are proud to announce that the first edition of the European Workshop on NASH in Clinical Practice was a huge success. The workshop took place from 22-23 November 2019 at the Crowne Plaza - Fira Centre Hotel.

The Organizing Committee and organizers would like to thank the speakers, chairs and all participants for their contribution to this meeting! Special thanks to the workshop sponsors: Gilead, ViiV and Genfit . Without their contributions this workshop would not have been made possible.

The slides of the presentations given during the meeting, provided the speaker's consent was received, will be available on this website. 

We look forward to seeing you again at the next edition of this meeting.

Committees
Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts. 

Scientific Committee

The members of Scientific Committee assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee actively participate in reviewing submitted abstracts.

  • Ina Bergheim, PhD, University of Vienna, Austria
  • Ali Canbay, MD, University Hospital Magdebrug, Germany
  • Bertrand Cariou, MD, PhD, Nantes University Hospital, France
  • Javier Crespo, MD, PhD, University of Cantabria, Spain
  • John Dillon, MD, University of Dundee, Scotland
  • Valérie Paradis, MD, PhD, Université Paris Diderot, France
  • Emmanuel Tsochatzis, MD, PhD, University College London, UK
Support
Contributor
Endorser
Language